tiprankstipranks
Hansoh Pharmaceutical Group Company Limited (HK:3692)
:3692
Hong Kong Market

Hansoh Pharmaceutical Group Company Limited (3692) Income Statement

Compare
3 Followers

Hansoh Pharmaceutical Group Company Limited Income Statement

Last quarter (Q2 2024), Hansoh Pharmaceutical Group Company Limited's total revenue was ¥6.51B, an increase of 46.71% from the same quarter last year. In Q2, Hansoh Pharmaceutical Group Company Limited's net income was ¥2.73B. See Hansoh Pharmaceutical Group Company Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 10.10B¥ 9.38B¥ 9.94B¥ 8.69B¥ 8.68B
Gross Profit
¥ 9.07B¥ 8.51B¥ 9.06B¥ 7.89B¥ 7.95B
Operating Expenses
¥ 6.23B¥ 5.84B¥ 5.97B¥ 4.95B¥ 5.12B
Depreciation and Amortization
¥ 366.38M¥ 344.60M¥ 278.47M¥ 233.27M¥ 201.55M
EBITDA
¥ 4.20B¥ 2.93B¥ 3.08B¥ 2.99B¥ 2.96B
Operating Income
¥ 2.84B¥ 2.61B¥ 2.82B¥ 2.77B¥ 2.78B
Other Income/Expenses
¥ 926.83M¥ 277.21M¥ 403.58M¥ 325.38M¥ 220.46M
Pretax Income
¥ 3.77B¥ 2.95B¥ 3.30B¥ 3.10B¥ 3.00B
Net Income
¥ 3.28B¥ 2.58B¥ 2.71B¥ 2.57B¥ 2.56B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 0.52¥ 0.44¥ 0.46¥ 0.44¥ 0.47
Diluted EPS
¥ 0.54¥ 0.44¥ 0.44¥ 0.44¥ 0.47
Weighted Average Shares Outstanding
6.27B 5.92B 5.92B 5.88B 5.48B
Weighted Average Shares Outstanding (Diluted)
6.02B 5.93B 6.00B 5.88B 5.48B
Currency in CNY

Hansoh Pharmaceutical Group Company Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis